Insights

Gathering insights about CMM…

Similar companies to CMM

CMM Tech Stack

CMM uses 8 technology products and services including RSS, Squarespace Commerce, Stimulus, and more. Explore CMM's tech stack below.

RSS
Content Management System
Squarespace Commerce
E-commerce
Stimulus
Javascript Frameworks
reCAPTCHA
Security
Google Tag Manager
Tag Management
X-Content-Type-Options
Web & Portal Technology
Google Analytics
Web Analytics
Adobe Fonts
Web Fonts

Media & News

Chemomab Therapeutics Ltd. Sponsored ADR (NASDAQ:CMMB) Sees Significant Growth in Short Interest
Chemomab Therapeutics Ltd. Sponsored ADR (NASDAQ: CMMB - Get Free Report) saw a significant growth in short interest in the month of December. As of December 31st, there was short interest totaling 18,047 shares, a growth of 100.7% from the December 15th total of 8,994 shares. Approximately 0.3% of the company's shares are short sold. Based
Jan 15, 2026 | www.defenseworld.net
Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology
— New Peer-Reviewed Publication Highlights Phase 2 SPRING Trial Data Supporting the Disease Modifying Potential of Nebokitug in PSC and Supports Advancement to a P hase 3 Registration Trial — TEL AVIV, Israel, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that the results of its Phase 2 SPRING trial assessing nebokitug in patients with primary sclerosing cholangitis (PSC) were published in the current issue of the American Journal of Gastroenterology.1 The study showed that nebokitug was generally safe and well tolerated in patients with PSC for up to 48 weeks of treatment.
Dec 02, 2025 | www.globenewswire.com
Chemomab to Participate in Oppenheimer's Movers in Rare Disease Summit
TEL AVIV, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that co-founder and CEO Adi Mor, PhD, will participate in Oppenheimer's Movers in Rare Disease Summit on Thursday, December 11, 2025, at the Sofitel Hotel in New York City.
Nov 24, 2025 | www.globenewswire.com
Chemomab Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update
—Nebokitug PSC Phase 3 Design Near Completion Following Positive FDA Feedback— —Regulatory Alignment Advances, with EMA Guidance Supporting a Single Nebokitug Phase 3 Registration Trial Using a Clinical Event Composite Endpoint — —Phase 2 SPRING Trial OLE Data Showing Favorable Safety and Consistent Improvements in Key Biomarkers in PSC Patients Treated with Nebokitug for Up to 48 Weeks Presented at AASLD 2025 — — New Clinical Data Presented at AASLD 2025 Provides Insights on Nebokitug's Direct Macrophage-Mediated Mechanisms that Are Relevant to Halting or Slowing PSC Disease Progression— —Multiple Partnering Options for Supporting the Nebokitug Phase 3 Program Continue to Advance— —Cash Runway Expected through End of Fourth Quarter of 2026— TEL AVIV, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced financial and operating results for the third quarter ended September 30, 2025, and provided a corporate update.
Nov 20, 2025 | www.globenewswire.com
Chemomab Announces Multiple Presentations at AASLD The Liver Meeting® 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis
Chemomab announced three presentations "of distinction" at AASLD The Liver Meeting® 2025 featuring clinical data from the nebokitug Phase 2 trial in PSC.
Nov 06, 2025 | www.globenewswire.com
Best Momentum Stocks to Buy for Oct. 23
PARR, CMMB and GES made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Oct. 23, 2025.
Oct 23, 2025 | www.zacks.com
New Strong Buy Stocks for Oct. 23: MQ, GES and More
MQ, GES, TRV, CMMB and PARR have been added to the Zacks Rank #1 (Strong Buy) List on Oct. 23, 2025.
Oct 23, 2025 | www.zacks.com

CMM's Email Address Formats

CMM uses at least 2 format(s):

CMM Email Formats	Example	Percentage
First@cmmconstruction.com	John@cmmconstruction.com	72%
FLast@cmmconstruction.com	JDoe@cmmconstruction.com	24%
F.Last@cmmconstruction.com	J.Doe@cmmconstruction.com	4%
Last@teamcmm.com	Doe@teamcmm.com	100%

Frequently Asked Questions

Where is CMM's headquarters located?

CMM's main headquarters is located at 1551 Highway 138 Suite 1 Wall, New Jersey United States. The company has employees across 6 continents, including North AmericaAfricaEurope.

What is CMM's phone number?

You can contact CMM's main corporate office by phone at

+1-732-455-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CMM's stock symbol?

CMM is a publicly traded company; the company's stock symbol is CMMB.

What is CMM's official website and social media links?

CMM's official website is teamcmm.com and has social profiles on LinkedIn.

What is CMM's NAICS code?

CMM's NAICS code is 2361 - Residential Building Construction.

How many employees does CMM have currently?

As of February 2026, CMM has approximately 84 employees across 6 continents, including North AmericaAfricaEurope. Key team members include President: A. C.President: C. M.President And Chief Executive Officer: M. M.. Explore CMM's employee directory with LeadIQ.

What industry does CMM belong to?

CMM operates in the Residential Building Construction industry.

What technology does CMM use?

CMM's tech stack includes RSSSquarespace CommerceStimulusreCAPTCHAGoogle Tag ManagerX-Content-Type-OptionsGoogle AnalyticsAdobe Fonts.

What is CMM's email format?

CMM's email format typically follows the pattern of First@cmmconstruction.com. Find more CMM email formats with LeadIQ.

When was CMM founded?

CMM was founded in 1983.

CMM

Q: What is CMM's official website and social media links?

CMM's official website is teamcmm.com. CMM has social profiles on LinkedIn.

Q: How many employees does CMM have currently?

CMM has approximately 84 employees.

Q: What technology does CMM use?

CMM's tech stack includes Stimulus, JSON-LD, Open Graph, HSTS, Squarespace.

Residential Building ConstructionNew Jersey, United States51-200 Employees

CMM builds custom homes on the Jersey Shore. Since 1983 CMM has been building in Southern Monmouth and Northern Ocean Counties. CMM strives to provide exceptional quality, a simple build process, and timeless designs for good living.